Understanding Female Hormones: Why They Matter for Your Long-Term Health

Hormones govern far more than your menstrual cycle. They influence your mood, energy levels, bone density, heart health, metabolism, and cognitive function. When they are balanced, you may barely notice them. When they are not, the effects can be felt across your entire body.

Understanding your hormonal health is not just about fertility or managing periods. It is about understanding one of the most important systems affecting your long-term wellbeing.

The Key Players

Oestrogen

Oestrogen is often called the primary female sex hormone, though its influence extends well beyond reproduction. It regulates the menstrual cycle, supports bone density, protects cardiovascular health, maintains skin elasticity, and affects mood and cognitive function.

Fluctuating oestrogen can cause irregular periods, hot flushes, vaginal dryness, mood changes, and over time, increased risk of osteoporosis and cardiovascular disease. High oestrogen relative to progesterone (oestrogen dominance) can cause heavy periods, breast tenderness, bloating, and may increase certain health risks.

Progesterone

Progesterone works alongside oestrogen to regulate the menstrual cycle. It prepares the uterine lining for pregnancy and helps maintain early pregnancy. Outside of reproduction, it has calming effects on the nervous system and supports sleep.

Low progesterone is associated with irregular cycles, premenstrual symptoms, difficulty sleeping, and early pregnancy loss. It often declines before oestrogen during the approach to menopause, contributing to perimenopausal symptoms.

Follicle-Stimulating Hormone (FSH)

FSH is produced by the pituitary gland and stimulates the ovaries to develop follicles, which contain eggs. Levels fluctuate throughout the menstrual cycle, rising at the start to trigger follicle development.

Elevated FSH, particularly in the early follicular phase, can indicate diminishing ovarian reserve. Persistently high FSH is one of the markers used to confirm menopause.

Luteinising Hormone (LH)

LH triggers ovulation. A surge in LH mid-cycle causes the dominant follicle to release an egg. Testing LH can help identify ovulation timing and, in combination with FSH, assess ovarian function.

An elevated LH to FSH ratio may suggest polycystic ovary syndrome (PCOS).

Prolactin

Prolactin is primarily known for stimulating breast milk production, but it also plays a role in menstrual regulation. Elevated prolactin (outside of pregnancy and breastfeeding) can suppress ovulation, cause irregular or absent periods, and sometimes cause breast discharge.

High prolactin may indicate a pituitary adenoma (usually benign) or be a side effect of certain medications.

Testosterone

Women produce testosterone too, just in smaller amounts than men. It contributes to libido, energy levels, muscle mass, and bone strength.

Low testosterone can cause fatigue, reduced sex drive, and low mood. Elevated testosterone, often seen in PCOS, can cause acne, excess facial or body hair, and irregular periods.

Why Hormone Testing Matters

Investigating Symptoms

If you are experiencing irregular periods, heavy bleeding, persistent fatigue, unexplained weight changes, mood disturbances, difficulty conceiving, or symptoms suggestive of perimenopause, hormone testing can help identify the cause.

Symptoms alone are often non-specific. A blood test provides objective data that guides diagnosis and treatment.

Assessing Fertility

For women planning pregnancy, hormone testing can assess ovarian reserve and identify conditions that might affect conception. FSH, LH, oestradiol, and anti-Müllerian hormone (AMH) are commonly measured in fertility assessments.

Confirming Perimenopause and Menopause

The transition to menopause is often diagnosed clinically based on symptoms and age. However, hormone testing can be helpful when symptoms are ambiguous, when menopause occurs early (before age 45), or when treatment decisions depend on confirming hormonal status.

Elevated FSH with low oestradiol in the context of irregular periods typically indicates perimenopause or menopause.

Monitoring Hormone Therapy

Women on hormone replacement therapy (HRT) or hormonal contraception may benefit from periodic testing to ensure hormone levels are optimised and to monitor for any imbalances.

When to Test

Hormone levels fluctuate throughout the menstrual cycle, so timing matters.

For general hormone profiling, testing is usually best performed on day 2 or 3 of your cycle (where day 1 is the first day of your period). This captures baseline levels before the hormonal shifts of ovulation.

If you are investigating ovulation, a progesterone test on day 21 (or 7 days after suspected ovulation) can confirm whether ovulation has occurred.

If your periods are irregular or absent, testing can be done at any time, with the understanding that interpretation may require additional context.

Hormones and Long-Term Health

Hormonal health is not just about reproductive function. The hormonal changes that occur during perimenopause and menopause have significant implications for long-term health.

Bone Health

Oestrogen protects bone density. After menopause, the decline in oestrogen accelerates bone loss, increasing the risk of osteoporosis and fractures. This is why bone density screening (DEXA scanning) is often recommended for postmenopausal women.

Our Advanced and Elite women's packages include DEXA scanning where clinically indicated.

Cardiovascular Health

Before menopause, women have lower rates of heart disease than men. After menopause, this advantage disappears. Oestrogen has protective effects on blood vessels and cholesterol profiles that diminish as levels fall.

Cardiovascular risk assessment, including lipid profiling and blood pressure monitoring, becomes increasingly important from midlife onwards.

Metabolic Health

Hormonal changes can affect metabolism, body composition, and insulin sensitivity. Many women notice weight changes during perimenopause despite no change in diet or exercise.

Screening for diabetes (HbA1c, fasting glucose) and metabolic markers helps identify issues early.

Cognitive Health

There is growing research into the relationship between oestrogen and brain health. Some women report cognitive changes during perimenopause, often described as brain fog or difficulty concentrating.

While the long-term implications are still being studied, maintaining overall metabolic and cardiovascular health appears to be protective for cognitive function.

What We Measure

Our female hormone profile includes:

• LH (luteinising hormone)
• FSH (follicle-stimulating hormone)
• Prolactin
• Oestradiol

For more comprehensive assessment, our Advanced women's screen adds thyroid function and vitamin D, while our Elite package includes consultation with our consultant gynaecologist, Mr Hikmat Naoum, along with transvaginal ultrasound and cervical screening.

The Ultimate women's package includes an extended hormone profile with testosterone, SHBG, and free androgen index, alongside full body MRI and ovarian tumour markers (CA-125, HE4, and ROMA scoring).

Taking Action

Hormone testing is a starting point, not an end in itself. Results need to be interpreted in context and, where abnormalities are found, appropriate follow-up arranged.

If testing reveals perimenopause or menopause, options include lifestyle modifications, HRT, and ongoing monitoring. If results suggest PCOS, thyroid dysfunction, or other conditions, specific treatment can be initiated.

Understanding your hormones gives you information. What you do with that information is what matters for your long-term health.

Book Your Assessment

Female hormone profiling is available as a standalone blood test or as part of our comprehensive women's health screening packages from £495.

For complex hormonal concerns or symptoms requiring specialist input, consultations with our Consultant Gynaecologist, Mr Hikmat Naoum, are available.

Call 020 7499 1991 or book online at healthscreening.clinic.

References

• NHS. Menopause. Available at: https://www.nhs.uk/conditions/menopause/
• Royal College of Obstetricians and Gynaecologists (RCOG). Management of Premenstrual Syndrome. Green-top Guideline No. 48. 2016.
• National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE guideline NG23. 2015 (updated 2019). Available at: https://www.nice.org.uk/guidance/ng23
• British Menopause Society. Menopause and long-term health. Available at: https://thebms.org.uk/publications/tools-for-clinicians/